Sclerosol (Bryan Corp)
Welcome to the PulseAid listing for the Sclerosol drug offered from Bryan Corp. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Bryan Corp |
NON-PROPRIETARY NAME: | Talc |
SUBSTANCE NAME: | TALC |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | INTRAPLEURAL |
DOSAGE FORM: | AEROSOL, POWDER |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2013-06-30 |
END MARKETING DATE: | 0000-00-00 |
Sclerosol HUMAN PRESCRIPTION DRUG Details:
Item Description | Sclerosol from Bryan Corp |
LABELER NAME: | Bryan Corp |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 4(g/25g) |
START MARKETING DATE: | 2013-06-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 63256-100_05246011-b7f0-40a3-ac67-b1bd8d23edac |
PRODUCT NDC: | 63256-100 |
APPLICATION NUMBER: | NDA020587 |
Other TALC Pharmaceutical Manufacturers / Labelers: